D.E. Shaw & Co
FNCH

D.E. Shaw & Co’s Finch Therapeutics Group, Inc. Common Stock FNCH Stock Holding History

D.E. Shaw & Co’s Portfolio FNCH Stock Details FNCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-639
Closed -$96K – 4593
2022
Q1 		$96K Sell
639
-276
-30% -$41.5K ﹤0.01% 3754
2021
Q4 		$274K Buy
+915
New +$274K ﹤0.01% 3355